Stocks and Investing
Stocks and Investing
Wed, November 25, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (ABEO) at Strong Buy with Decreased Target to $200 on, Nov 25th, 2020
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Abeona Therapeutics Inc." (ABEO) at Strong Buy with Decreased Target from $275 to $200 on, Nov 25th, 2020.
Raghuram has made no other calls on ABEO in the last 4 months.
There are 2 other peers that have a rating on ABEO. Out of the 2 peers that are also analyzing ABEO, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Kristen Kluska of "Cantor Fitzgerald" Upgraded from Hold to Buy and Held Target at $100 on, Wednesday, November 11th, 2020
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $125 on, Tuesday, November 10th, 2020
Contributing Sources